Detected ·

Waiv

——

Waiv (formerly Owkin Dx), an AI-powered precision medicine company, closed a $35M funding round with follow-on investment from CRB Health Tech SGEIC. The company has achieved CE marking for two clinical-grade tests and secured a pharma collaboration with Daiichi Sankyo for AI-derived biomarkers.

Amount
—
Stage
—
Event
Funding round
Detected
2026-05-07 12:08:49 UTC
Signal ID
389604b8-7d9f-4593-8e34-1ea729de42ed

As the API returns it

{
  "id": "389604b8-7d9f-4593-8e34-1ea729de42ed",
  "created_at": "2026-05-07T12:08:49.002703Z",
  "company_name": "Waiv",
  "company_website_url": "www.wearewaiv.com",
  "company_linkedin_url": "https://www.linkedin.com/company/we-are-waiv",
  "event_type": "funding",
  "funding_amount": null,
  "funding_currency": null,
  "funding_stage": null,
  "message": "*Waiv (formerly Owkin Dx), an AI-powered precision medicine company, closed a $35M funding round with follow-on investment from CRB Health Tech SGEIC. The company has achieved CE marking for two clinical-grade tests and secured a pharma collaboration with Daiichi Sankyo for AI-derived biomarkers.*"
}

Latest rounds